% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sha:300647,
author = {S. Sha$^*$ and R. Xie$^*$ and T. Gwenzi$^*$ and Y. Wang$^*$
and H. Brenner$^*$ and B. Schöttker$^*$},
title = {{R}eal-world evidence for an association of vitamin {D}
supplementation with atherosclerotic cardiovascular disease
in the {UK} {B}iobank.},
journal = {Clinical nutrition},
volume = {49},
issn = {0261-5614},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2025-00858},
pages = {118 - 127},
year = {2025},
note = {#EA:C070#LA:C070#},
abstract = {Atherosclerotic cardiovascular disease (ASCVD) remains a
substantial healthcare burden. The Australian D-Health trial
recently showed potential efficacy of vitamin D
supplementation (VDS) in reducing major ASCVD events.
Whether the efficacy could be translated into real-world
effectiveness is unclear.Leveraging data from the UK
Biobank, we used Cox regression with competing risk of
all-cause mortality to assess the association of
self-reported regular VDS (83.3 $\%$ from over-the-counter)
and serum 25-hydroxyvitamin D (25[OH]D) levels with ASCVD as
a composite endpoint and as separate endpoints including
ischemic heart disease (IHD), cerebrovascular disease,
peripheral arterial disease, and atherosclerotic
disease.Among 409,822 study participants aged 40-69 years,
20.7 $\%$ were vitamin D deficient (25[OH]D < 30 nmol/L) and
34.4 $\%$ were vitamin D insufficient (25[OH]D 30-<50
nmol/L). Regular VDS was reported by 4.3 $\%$ of the study
participants. During the follow-up of 15.9 years, 11.6 $\%$
of participants developed ASCVD. Compared to vitamin D
sufficiency, vitamin D deficiency was associated with a
significantly increased risk of the total ASCVD (hazard
ratio [95 $\%$ confidence interval]: 1.10 [1.07-1.13]) and
all separate ASCVD endpoints in the fully adjusted model
with 48 covariates. Consistently, compared to non-users, VDS
was associated with a reduced total ASCVD risk in the model
fully adjusted for the 50 covariates (0.94[0.90-0.98]).
Regarding the individual ASCVD disorders, VDS was associated
with reduced IHD risk (0.90[0.86-0.96]).Self-reported
regular VDS and being vitamin D sufficient were both
associated with reduced ASCVD risk in real-world settings.
For people with low 25(OH)D levels, regular VDS may be a
beneficial strategy for ASCVD prevention.},
keywords = {25-hydroxyvitamin D (Other) / Atherosclerotic
cardiovascular disease (Other) / Real-world evidence (Other)
/ Vitamin D supplement use (Other)},
cin = {C070 / C120},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40267517},
doi = {10.1016/j.clnu.2025.04.017},
url = {https://inrepo02.dkfz.de/record/300647},
}